first glp 1 on market New Demand in an Old GLP-1 Receptor Agonist Market Size,

Ikeji Last reviewed: 24 Sept 2025 GLP-1 patches are marketed as weight loss tools that conveniently deliver GLP-1-like effects, similar to medications like Mounjaro and Wegovy, but without the need for an injection

In an evidence-based approach, the key points contributing to this consensus with respect to the clinical impact and benefits of GLP-1 RAs and their use in special populations are as follows: Clinical impact of GLP-1 RAs: GLP-1 RAs improve glucose homeostasis by enhancing glucose-dependent insulin secretion, by suppressing inappropriately elevated glucagon levels, both in fasting and postprandial states (Grade A

doi:10.1016/S2213-8587(19)30311-0 Loos RJF, Yeo GS

Sirirak T, Sangsupawanich P, Wongpakaran N, Srisintorn W

Additionally, a large-scale observational study involving over 40,000 Chinese OA patients with comorbid T2DM reported that GLP-1RA therapies offered disease-modifying benefits [49]

On average, patients on this treatment drop 22.5% of their bodyweight